Citation Impact
Citing Papers
Health services utilization and cost utility analysis of a walking program for residential community elderly.
2008
Differences in Outcomes for Patients with Bacteremia Due to Vancomycin-Resistant Enterococcus faecium or Vancomycin-Susceptible E. faecium
1996
Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer
2008
Frailty in Older Adults: Evidence for a Phenotype
2001 Standout
Comprehensive molecular portraits of human breast tumours
2012 StandoutNature
Measuring the clinical consistency of panelists' appropriateness ratings: the case of coronary artery bypass surgery
1997
Lower-Extremity Function in Persons over the Age of 70 Years as a Predictor of Subsequent Disability
1995 Standout
Endogenous human microRNAs that suppress breast cancer metastasis
2008 StandoutNature
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
2014 Standout
A Multifactorial Intervention to Reduce the Risk of Falling among Elderly People Living in the Community
1994 Standout
Use of comprehensive geriatric assessment in older cancer patients:
2005
Global physical activity levels: surveillance progress, pitfalls, and prospects
2012 Standout
Preventing Falls in Elderly Persons
2003 Standout
Does obesity surgery improve psychosocial functioning? A systematic review
2003
New Mechanisms of Bacterial Resistance to Antimicrobial Agents
1991
Accuracy of magnetic resonance imaging for the diagnosis of multiple sclerosis: systematic review
2006
The Quality of Health Care Delivered to Adults in the United States
2003 Standout
The New Technology Assessment
1990
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
2005 Standout
Long-Term Morbidity and Mortality of Overweight Adolescents
1992 Standout
Comparison of the Quality of Ambulatory Care for Fee-for-Service and Prepaid Patients
1991
Body mass index at the age of 18 and its effects on 32-year-mortality from coronary heart disease and cancer A nested case-control study among the entire 1932 Dutch male birth cohort
1989
Relative weight and mortality in U.S. blacks and whites: Findings from representative national population samples
1997
Yale Ficsit: Risk Factor Abatement Strategy for Fall Prevention
1993
Future costs in cost effectiveness analysis
2008
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
The changing landscape of atherosclerosis
2021 StandoutNature
A Randomized, Controlled Trial of a Geriatric Assessment Unit in a Community Rehabilitation Hospital
1990
Long-Term Mortality after Gastric Bypass Surgery
2007 Standout
Coral reefs in the Anthropocene
2017 StandoutNature
The Influence of Inadequate Antimicrobial Treatment of Bloodstream Infections on Patient Outcomes in the ICU Setting
2000 Standout
Assessment of Quality-of-Life Outcomes
1996 Standout
Severe Sepsis and Septic Shock
2013 Standout
The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons
1991 Standout
Analyzing real-time PCR data by the comparative CT method
2008 Standout
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
2014 Standout
Antibacterial resistance worldwide: causes, challenges and responses
2004 Standout
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
2021 StandoutNobel
Should the consumption of survivors be included as a cost in cost–utility analysis?
2003
Assessing the quality of research
2004
Relationship of Childhood Abuse and Household Dysfunction to Many of the Leading Causes of Death in Adults
1998 Standout
Aspiration Pneumonitis and Aspiration Pneumonia
2001 Standout
Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold
2008
Chronic hepatitis B: Update 2009 #
2009 Standout
The Reproducibility of a Method to Identify the Overuse and Underuse of Medical Procedures
1998
Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report—Part II
2009
Expert opinion on the treatment of patients with chronic hepatitis C
2008
Hepatic Gene Expression Discriminates Responders and Nonresponders in Treatment of Chronic Hepatitis C Viral Infection
2005
Patient knowledge and antibiotic abuse: Evidence from an audit study in China
2011
Smokeless Tobacco and Aerodigestive Tract Cancers: Recent Research Directions
1992
Assessing the Predictive Validity of the RAND/UCLA Appropriateness Method Criteria for Performing Carotid Endarterectomy
1998
Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults
1999 Standout
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Head and Neck Cancer
1993 Standout
Vancomycin-Resistant Enterococcal Infections
2000 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
Home Visits to Prevent Nursing Home Admission and Functional Decline in Elderly People
2002
Impacts of Geriatric Evaluation and Management Programs on Defined Outcomes: Overview of the Evidence
1991
Costing and Perspective in Published Cost-Effectiveness Analysis
2009
Outcomes of Anatomical versus Functional Testing for Coronary Artery Disease
2015
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Antibiotic Resistance: Consequences of Inaction
2001
An In‐Home Preventive Assessment Program for Independent Older Adults: A Randomized Controlled Trial
1994
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
2007 Standout
Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold
2014 Standout
Frailty in elderly people
2013 Standout
Inconsistencies in the "Societal Perspective" on Costs of the Panel on Cost-Effectiveness in Health and Medicine
1999
The cancer genome
2009 StandoutNature
Life-cycle preferences over consumption and health: when is cost-effectiveness analysis equivalent to cost–benefit analysis?
1999
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
2011 Standout
Quality of Care for Medicare Patients With Acute Myocardial Infarction
1995
Epidemiology of Drug Resistance: Implications for a Post—Antimicrobial Era
1992 StandoutScience
The structure of psychological distress and well-being in general populations.
1983 Standout
Factors related to utilization of dental services by the elderly.
1982
Detection and Quantification of Hepatitis C Virus (HCV) by MultiCode-RTx Real-Time PCR Targeting the HCV 3′ Untranslated Region
2009
Evaluating the federal role in financing health-related research
1996 StandoutNobel
Smearing Estimate: A Nonparametric Retransformation Method
1983 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Good research practices for measuring drug costs in cost-effectiveness analyses: a societal perspective: the ISPOR Drug Cost Task Force report--Part II.
2010
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
Does Free Care Improve Adults' Health?
1983
Environmental Contributions to the Obesity Epidemic
1998 StandoutScience
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.
1992 Standout
Mathematical Modeling of Subgenomic Hepatitis C Virus Replication in Huh-7 Cells
2006 StandoutNobel
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses
2016 Standout
HDACs and HDAC Inhibitors in Cancer Development and Therapy
2016
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
The Evolution of Social Norms
2015
Sources of Variation and Bias in Studies of Diagnostic Accuracy
2004
Long-term Effects of Home Visitation on Maternal Life Course and Child Abuse and Neglect
1997
The impact of training informal health care providers in India: A randomized controlled trial
2016 StandoutScienceNobel
Overweight Children and Adolescents: Description, Epidemiology, and Demographics
1998
Works of Charles E. Phelps being referenced
A Phase I Study of Quisinostat (JNJ-26481585), an Oral Hydroxamate Histone Deacetylase Inhibitor with Evidence of Target Modulation and Antitumor Activity, in Patients with Advanced Solid Tumors
2013
Focusing Technology Assessment Using Medical Decision Theory
1988
The Methodologic Foundations of Studies of the Appropriateness of Medical Care
1993
The Value of Diagnostic Information to Patients With Suspected Multiple Sclerosis
1994
On the (Near) Equivalence of Cost-Effectiveness and Cost-Benefit Analyses
1991
Effect of Prenatal and Infancy Nurse Home Visitation on Government Spending
1993
Economic foundations of cost-effectiveness analysis
1997
Estimating Diagnostic Test Accuracy Using a "Fuzzy Gold Standard"
1995
The Cost-Effectiveness of Magnetic Resonance Imaging for Patients with Equivocal Neurological Symptoms
1997
National Institutes of Health Consensus Development Conference Statement: Geriatric Assessment Methods for Clinical Decision‐making
1988
First line treatment with weekly docetaxel, vinorelbine, and trastuzumab in HER2 overexpressing metastatic breast cancer (HER2+ MBC): A Minnie Pearl Cancer Research Network phase II trial
2004
Bug/drug resistance. Sometimes less is more.
1989
The Demand for Dental Care
1979
Some Interim Results from a Controlled Trial of Cost Sharing in Health Insurance
1981
First line treatment with weekly docetaxel, vinorelbine, and trastuzumab in HER2 overexpressing metastatic breast cancer (HER2+ MBC): A Minnie Pearl Cancer Research Network phase II trial
2004
A Blood-Based Gene Expression Test for Obstructive Coronary Artery Disease Tested in Symptomatic Nondiabetic Patients Referred for Myocardial Perfusion Imaging The COMPASS Study
2013
Variations in Medical Practice Use: Causes and Consequences
1993
Bug/Drug Resistance
1989